The Angiotensin Receptor Antagonists Market in the US is expanding as healthcare providers increasingly use angiotensin receptor blockers (ARBs) to manage hypertension and various cardiovascular and renal conditions. Market Overview The Angiotensin Receptor Antagonists Market was valued at US$ 15,454.06 Million in 2025 and is expected to reach US$ 26,636.16 Million by 2034,...